Diaverum is one of the world's leading renal care providers. Originally founded in Sweden, today it has 9,000 employees, caring for close to 30,000 patients in 20 countries in Europe, Latin America, Middle East/Asia and Australia.

Jiangsu Yueda Group Co., Ltd. is one of the top 520 state owned enterprises in China. It owns 2 listed companies and 30 subsidiary companies with about 40,000 employees and capital asset of over CNY 55 billion.

Diaverum and the Chinese Yueda Group has entered into a joint venture agreement aiming to provide renal care services in China.

Dolce&Gabbana and Shiseido Group announced the signature of a worldwide exclusive license agreement.

The agreement includes development, manufacturing and distribution of Dolce&Gabbana’s fragrance, makeup and skincare lines and products by Shiseido Group.

Dolce & Gabbana and Shiseido Group will officially start the collaboration as of October, 1st, 2016 (subject to antitrust authorities’ clearance).

Membres

* Barbara Levy
* Claire Poirson
* Laetitia Gavoty Tolot
* Louise Thiébaut

Clifford Chance has acted as lead counsel for Airbus Group on the finalisation of the original agreement signed in December 2014 with Safran on their Airbus Safran Launchers 50/50 Joint Venture, which becomes a fully-fledged operational company.

Airbus Safran Launchers was already managing launcher programme activities and associated equity stakes, and with this closing the company officially incorporates the parent companies' assets and subsidiaries related to its core business.

Stibbe advises Heijmans and Facilicom in connection with their joint venture for the Design, Build, Maintenance and Operation of the New Amsterdam Courthouse PPP project.

Roschier advised Nokia in its strategic patent licensing negotiations with Samsung resulting in expanded licensing arrangements between the two companies. Nokia further announced that, through this expansion, Nokia Technologies' annualized net sales related to IP licensing is expected to grow to a run rate of approximately EUR 950 million by the end of 2016. Thus, the deal will further reinforce Nokia's position as one of the top patent licensors in the world.

TOKYO, July 2016 – Hogan Lovells' Tokyo corporate team advised Paris-listed Neopost Group ("Neopost"), a global leader in mailing, postage, parcel delivery and shipping services, on the formation of a joint venture between its group company Neopost Shipping S.A. and Yamato Transport Co Ltd ("Yamato Transport"), Tokyo-listed and Japan's largest parcel delivery company, to operate an open network of secure automated parcel lockers for the delivery of parcels in Japan.

Clifford Chance has advised Allianz Real Estate on a joint venture between Allianz Group and Hammerson plc for the takeover of "Dundrum Town Centre" in Dublin.

The joint venture partners acquired the "Project Jewel" loan portfolio last year, which included loans secured against "Dundrum Town Centre". The deal was one of the largest loan disposals ever to take place in Ireland and Clifford Chance also advised Allianz Real Estate on that transaction.

TOKYO, July 2016 – Hogan Lovells' Tokyo corporate team advised Paris-listed Neopost Group ("Neopost"), a global leader in mailing, postage, parcel delivery and shipping services, on the formation of a joint venture between its group company Neopost Shipping S.A. and Yamato Transport Co Ltd ("Yamato Transport"), Tokyo-listed and Japan's largest parcel delivery company, to operate an open network of secure automated parcel lockers for the delivery of parcels in Japan.

Leading international law firm, Clifford Chance advised Rabobank on its strategic partnership with Kepler Cheuvreux, Europe’s leading independent broker. The investment ensures Rabobank’s corporate clients can benefit from better ECM and brokerage services as well as greater scale and scope. Together Rabobank and Kepler Cheuvreux will be the number 1 equity brokerage house in the Benelux.

Global law firm White & Case LLP has advised GHO Capital, the European specialist investor in healthcare, on its collaboration with investment firm Ardian for the acquisition of Envision Pharma Group.

"This transaction was a great opportunity to combine our experience of advising financial sponsors with our extensive healthcare and pharmaceutical industry capabilities," said White & Case partner Ian Bagshaw, who led the Firm's deal team, "It demonstrates our ability to support clients on their most important and complex matters across our worldwide network."